Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
GLP-1 Receptor Agonist | Once-Weekly Administration
Semaglutide is a GLP-1 receptor agonist that has been widely studied for its theoretical role in appetite regulation and glucose metabolism. Research suggests it may theoretically support weight management through once-weekly subcutaneous administration, making it one of the most discussed compounds in the metabolic wellness space.
GLP-1 Receptor Agonist | Once-Weekly Administration
Semaglutide is a GLP-1 receptor agonist that has been widely studied for its theoretical role in appetite regulation and glucose metabolism. Research suggests it may theoretically support weight management through once-weekly subcutaneous administration, making it one of the most discussed compounds in the metabolic wellness space.